Challenges of clinical translation in nanomedicine: A qualitative study.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nanomedicine : nanotechnology, biology, and medicine

• Publication date

  2016-05-01

• Fields of study

  Medicine, Materials Science, Engineering, Environmental Science

• Identifiers
  DOI 10.1016/j.nano.2015.12.376PMID 26772431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Theranostic nanomedicine.

  2020cited by this paper
• Nanomedicine applied to translational oncology: A future perspective on cancer treatment.

  2016cited by this paper
• Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?

  2016cited by this paper
• The challenges facing block copolymer micelles for cancer therapy: In vivo barriers and clinical translation.

  2015cited by this paper
• Delivering nanomedicines to patients: a practical guide.

  2015cited by this paper
• Horizon scan of nanomedicinal products.

  2015cited by this paper
• Nanoparticles in medicine: Current challenges facing inorganic nanoparticle toxicity assessments and standardizations.

  2015cited by this paper
• Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations.

  2015cited by this paper
• Clinical Translation of Nanomedicine.

  2015cited by this paper
• First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process.

  2015cited by this paper
• Rethinking risk assessment for emerging technology first-in-human trials

  2015cited by this paper
• Omics-based nanomedicine: the future of personalized oncology.

  2014cited by this paper
• Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease.

  2014cited by this paper
• Ethics of bioengineering organs and tissues

  2014cited by this paper
• Cancer nanomedicines: closing the translational gap.

  2014cited by this paper
• Rescuing US biomedical research from its systemic flaws

  2014cited by this paper
• Clinical translational challenges in nanomedicine

  2014cited by this paper
• Qualitative Research & Evaluation Methods: Integrating Theory and Practice

  2014cited by this paper
• Sampling in Interview-Based Qualitative Research: A Theoretical and Practical Guide

  2014cited by this paper
• Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.

  2013cited by this paper
• Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

  2013cited by this paper
• Facing the truth about nanotechnology in drug delivery.

  2013cited by this paper
• Smart drug delivery systems: back to the future vs. clinical reality.

  2013cited by this paper
• Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients.

  2013cited by this paper
• Challenges in Development of Nanoparticle-Based Therapeutics

  2012cited by this paper
• Fostering industry-science cooperation through public funding: differences between universities and public research centres

  2012cited by this paper
• Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance

  2012cited by this paper
• Is it Really All about the Money? Reconsidering Non-Financial Interests in Medical Research

  2012cited by this paper
• The Valley of Death in anticancer drug development: a reassessment.

  2012cited by this paper
• Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy

  2012cited by this paper
• Impact of public and private research funding on scientific production: The case of nanotechnology

  2012cited by this paper
• Nanomedicine(s) under the microscope.

  2011cited by this paper
• Translational research: understanding the continuum from bench to bedside.

  2011cited by this paper
• The long view of nanotechnology development: the National Nanotechnology Initiative at 10 years

  2011cited by this paper
• Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes.

  2011cited by this paper
• Nanosystem drug targeting: Facing up to complex realities.

  2010cited by this paper
• Gene Transfer and the Ethics of First-in-Human Research: Introduction: gene transfer lost in translation

  2009cited by this paper
• Nanomedicine and Society

  2009cited by this paper
• Naturalistic inquiry and the saturation concept: a research note

  2008cited by this paper
• The FDA critical path initiative and its influence on new drug development.

  2008cited by this paper
• First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials.

  2007cited by this paper
• Harm, ethics committees and the gene therapy death

  2001cited by this paper
• Annals of the New York Academy of Sciences Nanomedicines: Addressing the Scientific and Regulatory Gap

  year unknowncited by this paper

• Emerging Metallic Nanoparticle Modalities in Oral Squamous Cell Carcinoma: A Comprehensive Review on Theranostic Strategies and Future Perspectives.

  2026cites this paper
• Phytochemicals and REDOX Modulation: Molecular Mechanisms, Clinical Relevance, and Therapeutic Perspectives.

  2026cites this paper
• Spatiotemporal Nanocarriers for Circadian-Aligned Drug Delivery: Advances, Challenges, and Future Directions

  2026cites this paper
• Nanomedicines Reshape the Tumor Microenvironment: Multidimensional Strategies from Modulating “Barriers” to Metabolic Intervention

  2026cites this paper
• From Serum to Organ: The Amine-Naphthalene Modular Platform Enables Precise Identification and Quantification of Alkaline Phosphatase.

  2025cites this paper
• Graphene Oxide-Based Bio Nanocomposites for Hyperthermia-Driven Anticancer Therapy

  2025cites this paper
• Pathways to translation for nanomedicine in nephrology

  2025cites this paper
• Unlocking ferulic acid for neurological diseases and tailoring of nanoformulations to advance its brain delivery.

  2025cites this paper
• Nanotechnology-Driven Treatment Strategies for Breast Cancer: Recent Advances and Innovations

  2025cites this paper
• Prediction of silica nanoparticle biodistribution using a calibrated physiologically based model: Unbound fraction and elimination rate constants for the kidneys and phagocytosis identified as major determinants

  2025cites this paper
• Exploring the therapeutic potential of ligand-decorated nanostructured lipid carriers for targeted solid tumor therapy.

  2025cites this paper
• Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy.

  2025cites this paper
• Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment

  2025cites this paper
• Artificial intelligence-driven intelligent nanocarriers for cancer theranostics: A paradigm shift with focus on brain tumors.

  2025cites this paper
• Construction of 89Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging.

  2025cites this paper
• The therapeutic efficacy of nanoparticles in the treatment of alzheimer's disease.

  2025cites this paper
• Revolutionizing Arthritis Care: Cutting-Edge Nanogel Formulations for Targeted, Long-Lasting Relief and Enhanced Mobility

  2024cites this paper
• A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System

  2024cites this paper
• Advancing Autonomous Nanomedicine: Bridging the Gap from Concept to Potential Clinical Studies

  2024cites this paper
• Fluorinated macromolecular amphiphiles as prototypic molecular drones

  2024cites this paper
• Recent Advances in Nano-Based Drug Delivery Systems for Treatment of Liver Cancer.

  2024cites this paper
• Innovative horizons in cancer therapy, imaging, and sensing with Janus Nanoparticles: a comprehensive review

  2024cites this paper
• Advances in Targeted Nano-Delivery of Bevacizumab Using Nanoparticles: Current Insights, Innovations, and Future Perspectives

  2024cites this paper
• Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy

  2024cites this paper
• Metallic nanoparticles and treatment of cutaneous leishmaniasis: A systematic review.

  2024cites this paper
• Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects

  2023cites this paper
• Polysaccharide-based nanoassemblies: From synthesis methodologies and industrial applications to future prospects.

  2023cites this paper
• A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century

  2023cites this paper
• Understanding the Role of Radio-Sensitizing Nanoparticles in Enhancing Pathologic Response in Soft Tissue Sarcomas

  2023cites this paper
• Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review

  2023cites this paper
• Current advances of nanocellulose application in biomedical field.

  2023cites this paper
• Organic nanomaterials for near-infrared light-triggered photothermal/thermodynamic combination therapy

  2022cites this paper
• Investigators' sense of failure thwarted transparency in clinical trials discontinued for poor recruitment.

  2022cites this paper
• Nanotechnology in drug and gene delivery

  2022cites this paper
• Application of Chemically and Physically Synthesized Metal Nanoparticles to Staphylococcus aureus

  2022cites this paper
• Current Nano-therapeutic Approaches Ameliorating Inflammation in Cancer Progression.

  2022cites this paper
• A Facile Way To Improve the Bioavailability of Nanomedicine Based on the Threshold Theory.

  2022cites this paper
• Nanotechnology as a tool to overcome macromolecules delivery issues.

  2022cites this paper
• Liposomal formulations for treating lysosomal storage disorders.

  2022cites this paper
• The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells

  2022cites this paper
• Mg2+ Ions Regulating 3WJ-PRNA to Construct Controllable RNA Nanoparticle Drug Delivery Platforms

  2022cites this paper
• A state of the art in analytical quality-by-design and perspectives in characterization of nano-enabled medicinal products.

  2022cites this paper
• Theranostic nanoparticles engineered for clinic and pharmaceutics

  2021cites this paper
• Regulatory perspectives of nanomedicines for cancer treatment

  2021cites this paper
• Nanotechnology approaches for global infectious diseases

  2021cites this paper
• Introduction to Nanomedicines: Basic Concept and Applications

  2021cites this paper
• Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity.

  2021cites this paper
• Recent Advances in Liposomal-Based Anti-Inflammatory Therapy

  2021cites this paper
• pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.

  2021cites this paper
• Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines

  2021cites this paper
• Nanoparticle delivery of cardioprotective therapies.

  2020cites this paper
• Controlled drug release from polyelectrolyte-drug conjugate nanoparticles.

  2020cites this paper
• The relevance of nanotechnology, hepato-protective agents in reducing the toxicity and augmenting the bioavailability of isotretinoin

  2020cites this paper
• The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats

  2020cites this paper
• Counterion of Chitosan Influences Thermodynamics of Association of siRNA with a Chitosan-Based siRNA Carrier

  2020cites this paper
• Self-Nanoemulsifying System Loaded with Sildenafil Citrate and Incorporated within Oral Lyophilized Flash Tablets: Preparation, Optimization, and In Vivo Evaluation

  2020cites this paper
• Guidelines as a starting point to address the needs of small and medium enterprises regarding the Safe-by-Design of polymeric nanobiomaterials for drug delivery

  2020cites this paper
• A review on advances in graphene-derivative/polysaccharide bionanocomposites: Therapeutics, pharmacogenomics and toxicity.

  2020cites this paper
• An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market

  2020cites this paper
• Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery.

  2020cites this paper
• Investigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System

  2020cites this paper
• In Vitro-in Silico Modelling Approach to Rationally Design Simple and Versatile Drug Delivery Systems.

  2020cites this paper
• Readiness for First-In-Human Neuromodulatory Interventions

  2020cites this paper
• Challenges and opportunities for drug delivery to the posterior of the eye.

  2019cites this paper
• Nanoparticle and polymeric nanoparticle-based targeted drug delivery systems

  2019cites this paper
• Nanoscale Delivery System for Nutraceuticals: Preparation, Application, Characterization, Safety, and Future Trends

  2019cites this paper
• A hierarchical integration pyramid to increase translation of biomaterials based on recent successes in multiscale synthetic biomaterials research

  2019cites this paper
• PLGA scaffolds: building blocks for new age therapeutics

  2019cites this paper
• Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment

  2019cites this paper
• The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture.

  2019cites this paper
• A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles

  2019cites this paper
• Nanocarriers in Different Preclinical and Clinical Stages

  2019cites this paper
• Set of Highly Stable Amine- and Carboxylate-Terminated Dendronized Au Nanoparticles with Dense Coating and Nontoxic Mixed-Dendronized Form.

  2019cites this paper
• A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines

  2019cites this paper
• Future of microfluidics in research and in the market

  2019cites this paper
• Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake.

  2019cites this paper
• Nanomedicines for cancer therapy: current status, challenges and future prospects.

  2019cites this paper
• Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.

  2019cites this paper
• Potential applications and human biosafety of nanomaterials used in nanomedicine

  2018cites this paper
• The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly.

  2018cites this paper
• Polysaccharide‐Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside

  2018cites this paper
• Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples

  2018cites this paper
• Identification of regulatory needs for nanomedicines

  2018influential citation
• Endogenously Triggerable Ultrasmall-in-Nano Architectures: Targeting Assessment on 3D Pancreatic Carcinoma Spheroids

  2018cites this paper
• Protein-polysaccharide nanohybrids: Hybridization techniques and drug delivery applications.

  2018cites this paper
• Biomedical applications of carbon nanomaterials: Drug and gene delivery potentials

  2018cites this paper
• A synthetic dendritic cell platform for immune activation

  2018cites this paper
• Clinical usefulness of liposomal formulations in cancer therapy: lessons from the experiences of doxorubicin

  2018cites this paper
• A multilevel governance framework for regulation of nanomedicine in India

  2017cites this paper
• Peripheral Nerve Nanoimaging: Monitoring Treatment and Regeneration

  2017cites this paper
• PEG‐PCL‐based nanomedicines: A biodegradable drug delivery system and its application

  2017cites this paper
• Polymeric nanoparticles: Promising platform for drug delivery.

  2017cites this paper
• Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems

  2017cites this paper
• Applications of Bionanotechnology in Nanomedicine: A theoretical analysis

  2017cites this paper
• Ethical Issues in Translational Research: From the Bench to Theatre

  2016cites this paper
• Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine.

  2016cites this paper
• Nanomedicine translation from enabling technologies to the patient: focus on infectious diseases

  2016cites this paper